Insulin Secretion

Biomarker

Related News

GLP-1 Receptor Agonists: Fertility, Pregnancy Safety, and Treatment Considerations

Feb 18, 2026

GLP-1 receptor agonists like semaglutide and liraglutide may improve fertility through metabolic benefits but are not recommended during pregnancy. Current guidance advises discontinuing long-acting agents at least two months before conception.

Semaglutide and Other GLP-1 Peptides Show Significant Weight Loss Results in Clinical Studies

Feb 17, 2026

Semaglutide and other GLP-1 receptor agonists demonstrate substantial weight loss effectiveness through appetite regulation and blood sugar control, with clinical studies showing average reductions of 14.9% to 20.9% body weight.